Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03080116
Title Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomy (ARNEO)
Acronym ARNEO
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Universitaire Ziekenhuizen Leuven
Indications
Therapies
Age Groups: adult
Covered Countries BEL


No variant requirements are available.